Global Fund completes reorganization of workforce, tightens focus to 20 'high-impact countries'

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria "is cutting its workforce and tightening its focus on 20 countries hardest hit by AIDS, tuberculosis and malaria," Reuters reports. Gabriel Jaramillo, who took over as general manager of the fund in January, "said in a statement that the fund had completed a reorganization that would rebalance its workforce with 39 percent more people managing grants and 38 percent fewer in support roles," the news service notes.

"Jaramillo's promise to bring efficiency, accountability and results got a swift vote of confidence from the Bill & Melinda Gates Foundation, which pledged $750 million in January," Reuters states, adding, "But more is needed from governments, which have provided the bulk of the $22.6 billion that has been raised by the Geneva-based organization to date for its work in 150 countries, paying for 3.5 million antiretroviral drug treatments and nine million tuberculosis treatments." According to Reuters, "The fund plans to disburse about $3 billion this year and next, and more resources will now be focused on 20 'high-impact countries' that bear most of the burden of the three diseases, including Nigeria, China, India, Indonesia, and the Democratic Republic of Congo" (Miles, 5/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity unveils a new era of automated tuberculosis testing